Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer

May 4, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approves Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer

Post navigation

← Maya Distribution, LLC Recalls Dragon Label Kratom Because Of Possible Salmonella Contamination Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk →
Proudly powered by WordPress